Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
GlobeNewswire, Inc.
The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in healthy adult participants, met all its primary endpoints REYKJAVIK, Iceland, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alvotech...
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
GlobeNewswire, Inc.
REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and...
VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management
GlobeNewswire, Inc.
— QSIVA offers clinically meaningful weight loss supported by a well-established safety profile, now available at a reduced price across Nordics and Poland AMSTERDAM, March 25, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a...
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
GlobeNewswire, Inc.
ZUG, Switzerland, 16 March, 2026 -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology,...
Gold Just Hit $4,900. Palladium Is in a Tariff Squeeze. And One Greenland Deposit Just Reported a 45–55% PdEq Grade Uplift in Metal-Price Sensitivity Work
GlobeNewswire, Inc.
Issued on behalf of Greenland Mines Ltd The combined Pd-Au-Pt expression at Skaergaard — already one of the world’s largest undeveloped precious-metals systems — just stepped up by approximately 50% in the high-price sensitivity sceanario under...
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
GlobeNewswire, Inc.
— The lowered pricing structure is now available for 101.82 EUR per bottle at pharmacies throughout Finland AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the development...
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
GlobeNewswire, Inc.
— The lowered pricing structure is now available for 963,88 SEK per bottle at pharmacies throughout Sweden AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the development...
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
GlobeNewswire, Inc.
— The lowered pricing structure is now available for 798,86 DKK per bottle at pharmacies throughout Denmark AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the development...
Tests of fridges show positive results
GlobeNewswire, Inc.
BRUSSELS, March 17, 2026 (GLOBE NEWSWIRE) -- ESN (European Service Network S.A.) creates the communication materials and manages the communication campaign for JACOP 2024. ESN is part of a consortium led by EY, which was awarded a framework...
Hearing Loss Gene Therapy Market Size to Rise by 18.90% CAGR till 2035
GlobeNewswire, Inc.
Ottawa, April 29, 2026 (GLOBE NEWSWIRE) -- The global hearing loss gene therapy market size is calculated at USD 1.33 billion in 2026 and is expected to reach around USD 6.32 billion by 2035, growing at a CAGR of 18.90% for the forecasted period....
Greenland Mines (Nasdaq: GRML) Reports 45–55% PdEq Grade Uplift in Metal-Price Sensitivity at Skaergaard — While Western Critical Minerals Push Hits Inflection Point
GlobeNewswire, Inc.
Companies Mentioned: NASDAQ: GRML | NASDAQ: USAR KEY TAKEAWAYS Greenland Mines Ltd. (Nasdaq: GRML) has reported the results of an independent metal-price sensitivity analysis on its Skaergaard Project, completed by SLR Consulting, indicating PdEq...
Alex Lawton Becomes CEO of Clear Street U.K. Following FCA Approval
GlobeNewswire, Inc.
LONDON, May 06, 2026 (GLOBE NEWSWIRE) -- Clear Street ("Clear Street" or "the Company"), a cloud-native financial infrastructure technology firm on a mission to give sophisticated investors access to every asset in every market, through a unified...
High-Grade Iron and Copper/Gold Potential Confirmed at Minturn Prospect
GlobeNewswire, Inc.
Reykjavík, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Amaroq Ltd. (“Amaroq” or the “Company”) High-Grade Iron and Copper/Gold Potential Confirmed at Minturn Prospect ** Grades of up to 69.5% iron across 9km strike of surface magnetite ** – **Sampling...
Polypropylene Containers Market Trends & Size 2026-35
GlobeNewswire, Inc.
Ottawa, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The global polypropylene containers market generated revenue of USD 168.64 billion in 2025, and this figure is projected to grow to USD 252.04 billion in 2035, according to research conducted by Towards...
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
GlobeNewswire, Inc.
— The new pricing structure is made available as of February for 3.39 EUR per day at pharmacies throughout Finland AMSTERDAM, March 10, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the...
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
GlobeNewswire, Inc.
— The new pricing structure is made available as of February for 32,13 SEK per day at pharmacies throughout Sweden AMSTERDAM, March 10, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the...
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
GlobeNewswire, Inc.
— The new pricing structure is made available as of February for 26,63 DKK per day at pharmacies throughout Denmark AMSTERDAM, March 10, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the...
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
GlobeNewswire, Inc.
REYKJAVIK, Iceland, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Commission...
MAPS Celebrates 40 Years at a Defining Moment for Psychedelics
GlobeNewswire, Inc.
Founded in April 1986 to advance psychedelic research and knowledge, MAPS has raised more than $150 million, supported 45 studies, and shaped the global policy and cultural landscape of psychedelics.
Oculis to Participate in Upcoming Investor Conferences
GlobeNewswire, Inc.
ZUG, Switzerland, March 05, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with...
Sign up for:
Sci-Tech Press Iceland
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.